Filters

Latest News

2020-11-10 15:41:24

Innovative and generic & biosimilar pharmaceutical industries unite on commitment to equitable access to COVID-19 medicines and vaccines, while flagging where further help is needed from others

Geneva 10 November 2020 – On the occasion of the World Health Assembly, the world’s research-based and generic & biosimilar ...

Read More

2020-10-22 09:38:06

IFPMA launches Note for Guidance to help those acting on behalf of biopharmaceutical companies live up to its ethical business principles

GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers and Associations (IFPMA) published today ...

Read More

2020-10-13 12:00:39

IFPMA applauds APEC for trailblazing efforts to demonstrate return on ethics for SMEs through Vision 2025

GENEVA, 13 October 2020: Today, IFPMA joined hundreds of diverse stakeholders from more than 30 ...

Read More

2020-09-21 12:00:07

Innovative vaccine and medicine industry applaud country commitments to COVAX Facility

Vaccine makers, and biopharmaceutical industry more generally, are encouraged to see the broad international support ...

Read More

2020-09-03 09:29:26

Biopharma industry updates on COVID-19 treatments progress and warns about upholding regulatory standards of quality

Geneva, 3 September 2020 – Seven months into the pandemic, the innovative biopharmaceutical industry continues ...

Read More

2020-07-26 18:16:22

WADA and IFPMA strengthen collaboration in the protection of clean sport

Geneva / Montreal, 28 July 2020: The World Anti-Doping Agency (WADA) and the International Federation ...

Read More

2020-07-09 13:30:55

New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion

New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment ...

Read More

Latest Statement

2020-11-20 14:00:59

Biopharmaceutical representative joins new antibiotic resistance fighting United Nations group to avert looming superbugs public health

20 November 2020, The World Health Organization, the Food and Agriculture Organization and the World Organization for Animal Health announced ...

Read More

2020-11-18 10:00:15

Joint Statement On World Antimicrobial Awareness Week

New AMR Action Fund steps in to save collapsing antibiotic ...

Read More

2020-11-09 21:42:14

IFPMA/IGBA “Considerations on equitable access to COVID-19 medicines and vaccines”

New AMR Action Fund steps in to save collapsing antibiotic ...

Read More

2020-11-09 20:41:39

IFPMA Statement for the resumed 73rd WHA on agenda item 13.3 Influenza preparedness

New AMR Action Fund steps in to save collapsing antibiotic ...

Read More

2020-10-16 19:32:12

IFPMA statement on “Intellectual Property and COVID-19”

New AMR Action Fund steps in to save collapsing antibiotic ...

Read More

2020-10-13 17:53:39

Biopharmaceutical industry support EU regulators exceptional transparency measures and call other regulatory authorities to follow suit to help ensure confidence in the science and the decision-making

New AMR Action Fund steps in to save collapsing antibiotic ...

Read More

2020-10-06 08:58:12

IFPMA Statement for the Special session of the Executive Board on implementation of Resolution WHA73.1

New AMR Action Fund steps in to save collapsing antibiotic ...

Read More

mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig

Sadia Kaenzig - Communications Manager

Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.

mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol

Morgane De Pol - Communications and Public Affairs

Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.

A shared commitment to global health

Our Brouchure

2015 Edition

A shared commitment to global health

At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.


Our Logo

Full colour EPS format

Our Logo

Full colour PNG format


FULL Name LOGO

Full colour EPS format


FULL Name LOGO

Full colour PNG format

Hot Topic

Pharmacovigilance: Do your bit, play your part!

Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is

Read More

Interview

IFPMA 2015 interview series 'Biodiversity, human health, and pharma'

A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to

Read More

Our Blog

Latest Tweets

RT @planetmoney: The world produces 3 to 5 billion vaccine doses a year, for everything except the seasonal flu. To effectively inoculate t…
10
RT @FightTheFakes: #Fakemeds undermine trust in health systems and can have fatal consequences for patients. That's why this Patient Solida…
7
This month #WHOBulletin features a piece on the @AMRActionFund coauthored by our DG @ThomasCueni 👇🏼 https://t.co/MjIHNjj3Qp
We will be launching the 🆕 Africa Young Innovators for Health Award 2021 at the #GalienForumAfrica You don't want… https://t.co/A5XByu8O21
1 1